Mission
The Addario Lung Cancer Medical Institute (ALCMI) is a nonprofit organization dedicated to advancing lung cancer research. Partnering with premier oncology research institutions, ALCMI provides funding, resources, and expert teams to support investigator-initiated clinical trials in lung cancer. Their goal is to enhance the understanding of lung cancer risk factors, molecular mechanisms, and to foster therapeutic advancements to improve patient outcomes.
Basic Information
Tax-Exempt
Founded in
2008
EIN
26-1721868
Total Assets
$1.004 million
UN Sustainable Development Goals Supported
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.
Showing 2 of 2 goals
At a Glance
Accelerating Clinical Trials
We revolutionized remote, decentralized clinical trials that drive significant impact efficiently.
Innovative Research
Our research has resulted in a new understanding of lung cancer genomics and novel treatment pathways.
Community Involvement
We engage patients, advocates, and researchers to foster collaboration in lung cancer research initiatives.
Upcoming Events
2024 Latin America Conference on Lung Cancer
November 2024
A conference focusing on the latest advancements in lung cancer treatments and research.
Early Age Onset Cancer Symposium – 2024
November 2024
Discussion on challenges and advancements in treating early-age onset cancers.
2024 Masters in Thoracic Oncology Summit
November 2024
A summit dedicated to thoracic oncology professionals to share insights and research.
MIP Score (Beta)
The MIP Score is in beta! We'd love any feedback you may have.
The MIP Score and it's methodology is purely used as a way to visualize how a nonprofits public financial data compares against others. It doesn't reflect the unique circumstances and impact that a nonprofit has.The MIP Score should never be used to say one charity is better than another.
Overall Score
57
50
/100
Program Expense Ratio
85.36%
16
/20
Program Revenue Growth
-35.13%
2
/20
Leverage Ratio
0.07117
20
/20
Working Capital Ratio
0.9437
10
/20
Fundraising Efficiency
0
2
/20
Latest Filing Data: Form 990
Fiscal Year:2022
Source:Source: Self-reported by organization
Financial Details
Revenue
| Category | Amount | Percentage |
|---|---|---|
| Contributions, Gifts, and Grants | 622.9K | 58.66% |
| Program Services | 439K | 41.34% |
| Investment Income | 90 | 0.01% |
| Sales of Non-Inventory Assets | 0 | 0.00% |
| Other Notable Sources | 0 | 0.00% |
| Total Revenue | 1.062M | 100.00% |
Related Nonprofits
American Dermatological Association Research and Educational Fund Inc.
Med Research
Lung Disease ResearchPulmonary Care Collaborative Limited
Med Research
Lung Disease ResearchRespire Health Foundation
Med Research
Lung Disease ResearchAspen Lung Conference
Med Research
Lung Disease ResearchPeter and Tommy Fund Inc. C/O Gary L Mucci
Med Research
Lung Disease Research